106 related articles for article (PubMed ID: 4194160)
1. Thromboplastin as a reagent.
Quick AJ
Thromb Diath Haemorrh; 1970 Jun; 23(3):585-92. PubMed ID: 4194160
[No Abstract] [Full Text] [Related]
2. Criteria for an acceptable thromboplastin preparation.
Owren PA
Thromb Diath Haemorrh; 1975 Apr; 33(2):165-71. PubMed ID: 49085
[No Abstract] [Full Text] [Related]
3. The influence of residual factor VII on the sensitivity of brain thromboplastin.
Spurling NW; Savory J
Thromb Haemost; 1978 Jun; 39(3):592-9. PubMed ID: 705687
[TBL] [Abstract][Full Text] [Related]
4. Optimization of prothrombin time measurements in canine plasma.
Mischke R; Nolte I
Am J Vet Res; 1997 Mar; 58(3):236-41. PubMed ID: 9055967
[TBL] [Abstract][Full Text] [Related]
5. Proposed specification for a reference thromboplastin preparation for the control of anticoagulant therapy using coumarin type drugs.
Denson KW
Thromb Diath Haemorrh Suppl; 1967; 26():437-40. PubMed ID: 6064874
[No Abstract] [Full Text] [Related]
6. Standardization of the prothrombin time: clinical results with a recombinant tissue factor reagent.
Kolde HJ
Haematologica; 1995; 80(2 Suppl):7-13. PubMed ID: 7628775
[No Abstract] [Full Text] [Related]
7. Standardization of thromboplastin reagents and control plasmas.
Owren PA
Haematologia (Budap); 1974; 8(1-4):441-54. PubMed ID: 4461430
[No Abstract] [Full Text] [Related]
8. [Comparison of prothrombin time reagent (Thromborel) and activated partial thromboplastin time reagent (Pathromtin) from human placenta with those from rabbit brain in laboratory practice (author's transl)].
Matsuoka M; Kobayashi I; Ito M; Sakuragawa N; Jimbo C; Hattori A; Watanabe T; Takahashi K; Hoshiyama M; Iizumi T; Sanada M; Ashizawa T; Takahashi H; Honda H; Shinada S
Rinsho Ketsueki; 1978 Jan; 19(1):22-30. PubMed ID: 564980
[No Abstract] [Full Text] [Related]
9. PLASMA PROTHROMBIN ACTIVATION IN HEMORRHAGIC DISORDERS.
PENNER JA
Am J Clin Pathol; 1964 Dec; 42():561-71. PubMed ID: 14239431
[No Abstract] [Full Text] [Related]
10. A high-sensitivity thromboplastin reagent prepared from cultured human cells.
Valdes-Camin R; Callahan JB; Ebert RF
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):617-24. PubMed ID: 7841320
[TBL] [Abstract][Full Text] [Related]
11. Artificial reagents for factor VII and factor X, a computer programme for obtaining reference tables for one-stage determinations in the extrinsic system.
Hemker HC; Swart AC; Alink AJ
Thromb Diath Haemorrh; 1972 Apr; 27(2):205-11. PubMed ID: 5049610
[No Abstract] [Full Text] [Related]
12. The use of tissue thromboplastins of different origin is a fundamental tool in the initial characterization of FVII defects on "factor VII deficiency (Semin Thromb Hemost 2009;35(4):400-406)".
Girolami A; Scandellari R; Lombardi AM
Semin Thromb Hemost; 2010 Feb; 36(1):123-4; author reply 125-7. PubMed ID: 20391303
[No Abstract] [Full Text] [Related]
13. [Thromboplastic activity of brain extracts from various species in normal plasma and in congenital factor VII deficient plasma from dogs].
von Schaewen H
Berl Munch Tierarztl Wochenschr; 1972; 85(8):149-52. PubMed ID: 5027610
[No Abstract] [Full Text] [Related]
14. Congenital "hypoprothrombinemias". Deficiency of factors II, VII, and X.
Seeler RA
Med Clin North Am; 1972 Jan; 56(1):127-32. PubMed ID: 4550186
[No Abstract] [Full Text] [Related]
15. The response of Quick's prothrombin time test to oral anticoagulation. Influence of thromboplastin source and calcium chloride concentration.
van den Besselaar AM
Arch Pathol Lab Med; 1994 Feb; 118(2):145-9. PubMed ID: 8311653
[TBL] [Abstract][Full Text] [Related]
16. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids.
Bader R; Mannucci PM; Tripodi A; Hirsh J; Keller F; Solleder EM; Hawkins P; Peng M; Pelzer H; Teijidor LM
Thromb Haemost; 1994 Mar; 71(3):292-9. PubMed ID: 8029792
[TBL] [Abstract][Full Text] [Related]
17. Two-stage procedure for the quantitative determination of autoprothrombin 3 concentration and some applications.
Reno RS; Seegers WH
Thromb Diath Haemorrh; 1967 Aug; 18(1-2):198-210. PubMed ID: 4169263
[No Abstract] [Full Text] [Related]
18. The critical evaluation of thromboplastin.
Ziegler FD; Kelly JH
Ann Clin Lab Sci (1971); 1972; 2(1):16-25. PubMed ID: 4563046
[No Abstract] [Full Text] [Related]
19. THE ACTIVATION OF FACTOR X BY EXTRACTS OF RABBIT BRAIN.
NEMERSON Y; SPAET TH
Blood; 1964 May; 23():657-68. PubMed ID: 14142504
[No Abstract] [Full Text] [Related]
20. Inhibitor of human blood coagulation elicited by thrombin.
Marciniak E
J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460
[No Abstract] [Full Text] [Related]
[Next] [New Search]
